EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Discrepancy Analysis between Histology and Molecular Diagnoses in Kidney Allograft Biopsies: A Single-Center Experience

Liye Suo iD, Martha Caicedo Murillo, Brian Gallay, Reut Hod-Dvorai iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241813817 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Liye Suo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The State University of New York Upstate Medical University (SUNY Upstate Medical University), Syracuse, NY 13210, USA. Hauptthemen laut MEDLINE: Kidney Transplantation, Kidney Diseases. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Histology diagnosis is essential for the monitoring and management of kidney transplant patients. Nowadays, the accuracy and reproducibility of histology have been criticized when compared with molecular microscopy diagnostic system (MMDx). Our cohort included 95 renal allograft biopsies with both histology and molecular diagnoses. Discrepancies between histology and molecular diagnosis were assessed for each biopsy. Among the 95 kidney allograft biopsies, a total of 6 cases (6%) showed clear (n = 4) or borderline (n = 2) discrepancies between histology and molecular diagnoses. Four out of the six (67%) were cases with pathologically and clinically confirmed active infections that were diagnosed as mild to moderate T-cell-mediated rejection (TCMR) with MMDx. Two cases showed pathological changes that were not sufficient to make a definitive diagnosis of active rejection via histology, while MMDx results showed antibody-mediated rejection (ABMR). In addition, there were six cases with recurrent or de novo glomerular diseases diagnosed only via histology. All other biopsy results were in an agreement. Our results indicate that histology diagnosis of kidney allograft biopsy is superior to molecular diagnosis in the setting of infections and glomerular diseases; however, MMDx can provide helpful information to confirm the diagnosis of active ABMR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationKidney DiseasesHumansReproducibility of ResultsGraft RejectionBiopsyAntibodiesKidneyAllograftsDoxorubicin

Stichwörter der Autor:innen

histologyinfectionkidney transplantmolecular diagnosis

Substanzen

Antibodiesmethoxy-morpholinyl-doxorubicinDoxorubicin

Autor:innen und Institutionen

  • Department of Pathology, The State University of New York Upstate Medical University (SUNY Upstate Medical University), Syracuse, NY 13210, USA.
  • Division of Nephrology and Transplantation, The State University of New York Upstate Medical University (SUNY Upstate Medical University), Syracuse, NY 13210, USA.

ORCID-Profile: Liye Suo, Reut Hod-Dvorai

Zitieren

APA

Suo, L., Murillo, M. C., Gallay, B., & Hod-Dvorai, R. (2023). Discrepancy Analysis between Histology and Molecular Diagnoses in Kidney Allograft Biopsies: A Single-Center Experience. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241813817

Vancouver

Suo L, Murillo MC, Gallay B, Hod-Dvorai R. Discrepancy Analysis between Histology and Molecular Diagnoses in Kidney Allograft Biopsies: A Single-Center Experience. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241813817

BibTeX
@article{Suo2023,
  author = {Suo, Liye and Murillo, Martha Caicedo and Gallay, Brian and Hod-Dvorai, Reut},
  title = {Discrepancy Analysis between Histology and Molecular Diagnoses in Kidney Allograft Biopsies: A Single-Center Experience},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241813817}
}
Kostenlos starten →